Filter Results:
(5,432)
Show Results For
- All HBS Web
(5,432)
- People (18)
- News (2,019)
- Research (2,721)
- Events (7)
- Multimedia (222)
- Faculty Publications (1,989)
Show Results For
- All HBS Web
(5,432)
- People (18)
- News (2,019)
- Research (2,721)
- Events (7)
- Multimedia (222)
- Faculty Publications (1,989)
- 16 Mar 2020
- Research & Ideas
How the Coronavirus Is Already Rewriting the Future of Business
With COVID-19 cases growing worldwide, business leaders are scrambling to deal with a wide variety of problems, from slumping sales and stalling supply chains to keeping employees healthy and making sure they can continue working. We asked professors of Harvard... View Details
Keywords: by Dina Gerdeman
- Web
Rigorous research, rooted in practice | About
in industries and organizations where economic models and operations are being disrupted from every angle. Faculty Case Studies Initiatives & Projects Bold ideas that become a powerful catalyst for change. Business & Environment Business History Entrepreneurship (Rock... View Details
- 08 Oct 2013
- First Look
First Look: October 8
Thomas H. Lee Abstract—In health care, the days of business as usual are over. Around the world, every health care system is struggling with rising costs and uneven quality,... View Details
Keywords: Sean Silverthorne
- 26 Feb 2019
- First Look
New Research and Ideas, February 26, 2019
https://www.hbs.edu/faculty/Pages/item.aspx?num=55694 forthcoming Journal of Monetary Economics U.S. Monetary Policy and Emerging Market Credit Cycles By: Bräuning, Falk, and Victoria Ivashina Abstract— Foreign banks’ lending to firms in... View Details
Keywords: Dina Gerdeman
- January 2018 (Revised January 2019)
- Case
ZappRx
By: Jeffrey J. Bussgang and Olivia Hull
In October 2015, ZappRx founder Zoe Barry is deciding between two business models for her health technology start-up. Her product, a software application that aims to expedite the prescription fulfillment process for patients with rare diseases, has attracted interest... View Details
- November 2022
- Case
The Battle Among Channels for Marketing Pharmaceuticals: UpScript, Pharmacy Benefit Managers, and Direct-to-Consumer Sales
By: Regina E. Herzlinger and Tiffany Farrell
Can an online, direct-to-consumer pharmacy both improve the quality and speed of care for patients who need branded drugs and stabilize profits for pharmaceutical manufacturers? UpScript, after years spent achieving legal and regulatory compliance and simultaneous... View Details
Keywords: DTC; Internet and the Web; Marketing Channels; Customer Value and Value Chain; Governing Rules, Regulations, and Reforms; Competitive Strategy; Service Delivery; Growth and Development Strategy; Health Industry; Health Industry; Health Industry
Herzlinger, Regina E., and Tiffany Farrell. "The Battle Among Channels for Marketing Pharmaceuticals: UpScript, Pharmacy Benefit Managers, and Direct-to-Consumer Sales." Harvard Business School Case 323-031, November 2022.
- September 2009
- Case
The Risk Management Foundation of the Harvard Medical Institutions, Inc.
By: Richard M.J. Bohmer, Stephen P. Bradley and Natalie Kindred
Through its uniquely proactive approach to medical malpractice risk management, the Risk Management Foundation (RMF) has decreased claims—and premiums—for the Harvard hospitals it insures. The RMF is the captive medico-legal insurer of the Harvard medical institutions... View Details
Keywords: Cost Management; Insurance; Health Care and Treatment; Risk Management; Performance Improvement; Safety; Health Industry; Health Industry; Boston
Bohmer, Richard M.J., Stephen P. Bradley, and Natalie Kindred. "The Risk Management Foundation of the Harvard Medical Institutions, Inc." Harvard Business School Case 610-014, September 2009.
- Web
Faculty & Staff - Institute For Strategy And Competitiveness
kahern@hbs.edu Dashka Bernard Program Manager, Health Care Fax: 617-496-7392 Email: dbernard@hbs.edu Richard Bryden Director of Information Products Phone: 617-495-6777 Fax: 617-384-7268 Email:... View Details
- 14 Jan 2019
- Op-Ed
These 4 CEOs Created a New Standard of Leadership
Mayo Clinic in 2009, the world-famous medical center was struggling financially. Congress would soon be negotiating the terms of the Affordable Care Act (ACA), the Obama Administration’s signature health... View Details
- 23 Apr 2024
- In Practice
Getting to Net Zero: The Climate Standards and Ecosystem the World Needs Now
With each month clocking record-breaking temperatures across the planet, this Earth Day reflected the renewed urgency of regulators and businesses to find climate-change solutions. The US Securities and Exchange Commission recently adopted new rules that will mandate... View Details
Keywords: by Rachel Layne
- June 2013
- Case
Ron Ventura at Mitchell Memorial Hospital
By: Frank V. Cespedes and Heide Abelli
Mitchell Memorial Hospital is a 750-bed regional academic medical center in Ohio. Andy Prescott, Chief of the Cardiovascular Center, is reviewing the performance evaluations of his star vascular surgeon Ron Ventura. The evaluations, the result of a 360-degree... View Details
Keywords: Performance Expectations; Conflict Management; Behavior; Groups and Teams; Organizational Culture; Resignation and Termination; Health Care and Treatment; Performance Evaluation; Health Industry; Ohio
Cespedes, Frank V., and Heide Abelli. "Ron Ventura at Mitchell Memorial Hospital." Harvard Business School Brief Case 913-572, June 2013.
- 10 Aug 2015
- Research & Ideas
New Medical Devices Get To Patients Too Slowly
device was defined using the FDA's standard as one that "supports or sustains human life or is of substantial importance in preventing impairment of human health or presents a potential, unreasonable risk of illness or injury.") The... View Details
- January 2024
- Article
Cost of Exempting Sole Orphan Drugs from Medicare Negotiation
By: Matthew Vogel, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim and Benjamin N. Rome
Importance: The Inflation Reduction Act (IRA) requires Medicare to negotiate prices for some high-spending drugs but exempts drugs approved solely for the treatment of a single rare disease.
Objective: To estimate Medicare spending and global... View Details
Objective: To estimate Medicare spending and global... View Details
Vogel, Matthew, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim, and Benjamin N. Rome. "Cost of Exempting Sole Orphan Drugs from Medicare Negotiation." JAMA Internal Medicine 184, no. 1 (January 2024): 63–69.
- 22 Feb 2023
- Blog Post
Meet the Disability Advocacy and Affinity Group (DAAG)
The Disability Advocacy and Affinity Group (DAAG)) has a mission to destigmatize the experience of living with or being the caretaker of someone with a disability. We cherish the unique perspectives that individuals with disabilities bring to every academic,... View Details
- October 2009
- Case
Medisys Corp.: The IntensCare Product Development Team
By: Anne Donnellon and Joshua D. Margolis
Key topics include designing teams, managing teams, managing conflict, group dynamics, project management, product development, interdepartmental relations, and organizational change. MediSys, a U.S.-based medical equipment maker, has been developing IntensCare, a new... View Details
Keywords: Project Management; Interdepartmental Relations; Organizational Change; Leadership; Conflict Management; Interpersonal Communication; Groups and Teams; Product Design; Product Development; Organizational Change and Adaptation; Health Care and Treatment; Power and Influence; Medical Devices and Supplies Industry; United States
Donnellon, Anne, and Joshua D. Margolis. "Medisys Corp.: The IntensCare Product Development Team." Harvard Business School Brief Case 094-059, October 2009.
- 31 Jan 2014
- Working Paper Summaries
The Diseconomies of Queue Pooling: An Empirical Investigation of Emergency Department Length of Stay
- 16 Jan 2013
- Research & Ideas
The Messy Link Between Slave Owners and Modern Management
it was also built on the backs of slaves who were literally the opposite of free. "It's a much bigger, more powerful question to ask, If today we are using management techniques that were also used on slave plantations," she says, "how much more View Details
Keywords: by Katie Johnston
- October 2022
- Case
Cost Plus Drugs
By: Alexander MacKay and James Barnett
In September 2022, Mark Cuban Cost Plus Drugs Company CEO Alex Oshmyansky considered the future of the company. Cost Plus Drugs was a retailer for more than 340 generic oral medications, selling their drugs at significantly lower prices than typical pharmacies.... View Details
Keywords: Business Ventures; Decision Making; Entrepreneurship; Ethics; Health; Markets; Social Enterprise; Society; Strategy; Health Care and Treatment; Business Divisions; Factories, Labs, and Plants; Health Industry; Health Industry; United States; Texas
MacKay, Alexander, and James Barnett. "Cost Plus Drugs." Harvard Business School Case 723-362, October 2022.
- 20 Dec 2022
- Op-Ed
Employee Feedback: The Key to Retention During the Great Resignation
“Great Resignation” and other challenges from a constantly changing competitive landscape? First, these companies have CEOs—indeed, leaders at all levels—who care equally about profits and employee well-being and don’t see them as... View Details
Keywords: by Michael Beer